Fundraising Fox

Axoft

Cambridge, US · Founded 2021 · Delaware corporation · 9 known investors

axoft.us ↗

Axoft develops soft neural implants and brain-computer interface technology for research and clinical applications. The company uses biocompatible materials and minimally-invasive surgical techniques to establish bidirectional communication with the brain.

BiotechDeep TechMedical Devicesin /axoftus

Founders & leadership

PL
Paul Le FlochinExecutive Officer, Director30 Under 30 2022
CA
Chia An LeeDirector
BP
Benjamin PlessDirector
RS
Rachel ShaDirector
TY
Tianyang YeDirector

Investors · 9

Archerman CapitalBoston
Blindspot Ventures Management CoBoston
Castor Ventures (an Alumni Ventures Fund)
Creative Destruction Lab (CDL)Toronto · $50K – $250K
Safar PartnersCambridge
The Engine VenturesCambridge
Alumni VenturesreportedManchester · $100K – $10M
Gaorong VenturesreportedGeorge Town, Grand Cayman · $2.8M – $120M
Hillhouse InvestmentreportedSingapore

Reported raises · per SEC filings

Form D private placements
▶$34.2MraisedMay 2026 · 13 investors · Biotechnology
Rule 506(b)
Axoft Secures $55 Million in Series A Funding | Medical Product Outsourcingmpo-mag.com · Jul 2026Axoft Raises $55M to Transform Brain-Machine Tech - Ventureburnventureburn.com · May 2026
Officers, directors & promoters on the filing
  • Paul Le FlochExecutive Officer, Director
  • Chia An LeeDirector
  • Benjamin PlessDirector
Offering amount
$34.2M
Amount sold
$34.2M
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.8MraisedMar 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin PlessDirector
  • Rachel ShaDirector
  • Paul Le FlochExecutive Officer, Director
  • Tianyang YeDirector
Offering amount
$9.3M
Amount sold
$8.8M
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2024 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin PlessDirector
  • Paul Le FlochExecutive Officer, Director
  • Rachel ShaDirector
  • Tianyang YeDirector
Offering amount
$5M
Amount sold
$500K
First sale
Feb 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news